Articles with public access mandates - Marwan SabbaghLearn more
Not available anywhere: 19
Review
Reduced risk of incident AD with elective statin use in a clinical trial cohort
DL Sparks, RJ Kryscio, MN Sabbagh, DJ Connor, LM Sparks, C Liebsack
Current Alzheimer Research 5 (4), 416-421, 2008
Mandates: US National Institutes of Health
Review
REM sleep behavior disorder and neuropathology in Parkinson's disease
RB Postuma, CH Adler, BN Dugger, JG Hentz, HA Shill, ...
Movement Disorders 30 (10), 1413-1417, 2015
Mandates: US National Institutes of Health
Review
Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease
JN Caviness, JG Hentz, CM Belden, HA Shill, ED Driver-Dunckley, ...
Journal of Parkinson's disease 5 (1), 117-124, 2015
Mandates: US National Institutes of Health
Review
Investigational drugs in Alzheimer's disease: current progress
C Berk, G Paul, M Sabbagh
Expert opinion on investigational drugs 23 (6), 837-846, 2014
Mandates: US National Institutes of Health
Review
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts
JN Caviness, RL Utianski, JG Hentz, TG Beach, BN Dugger, HA Shill, ...
European journal of neurology 23 (2), 387-392, 2016
Mandates: US National Institutes of Health
Review
Neuroimaging in dementias
S Mahalingam, MK Chen
Seminars in Neurology 39 (02), 188-199, 2019
Mandates: US National Institutes of Health
Review
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
GD Pal, B Ouyang, G Serrano, HA Shill, C Goetz, G Stebbins, LV Metman, ...
Movement Disorders 32 (2), 274-277, 2017
Mandates: US National Institutes of Health
Review
Neuropathological findings in Parkinson's disease with mild cognitive impairment
MG Knox, CH Adler, HA Shill, E Driver‐Dunckley, SA Mehta, C Belden, ...
Movement Disorders 35 (5), 845-850, 2020
Mandates: US National Institutes of Health, Michael J Fox Foundation
Review
Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's
E Delvaux, D Mastroeni, J Nolz, N Chow, M Sabbagh, RJ Caselli, ...
Neurobiology of aging 58, 225-237, 2017
Mandates: US National Institutes of Health
Review
Statins to treat Alzheimer’s disease: an incomplete story
MN Sabbagh, DL Sparks
Expert Review of Neurotherapeutics 12 (1), 27-30, 2012
Mandates: US National Institutes of Health
Review
The effect of healthy aging and mild cognitive impairment on semantic ambiguity detection
T Azuma, MN Sabbagh, DJ Connor
Journal of Neurolinguistics 26 (2), 271-282, 2013
Mandates: US National Institutes of Health
Review
Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?
MN Sabbagh, B DeCourt
Nature Reviews Neurology 19 (2), 71-72, 2023
Mandates: US National Institutes of Health
Review
Unmet needs in the diagnosis and treatment of Parkinson’s disease psychosis and dementia-related psychosis
M Sabbagh, GW Small, SH Isaacson, Y Torres-Yaghi, F Pagan, R Pahwa
International journal of psychiatry in clinical practice 27 (1), 69-81, 2023
Mandates: Parkinson's Foundation, USA
Review
Type 2 diabetes comorbidity and cognitive decline in patients with Alzheimer’s disease
S Davidson, G Allenback, B Decourt, MN Sabbagh
Journal of Alzheimer's Disease, 1-12, 2023
Mandates: US National Institutes of Health
Review
Alzheimer’s disease beyond amyloid
J Shi, MN Sabbagh, B Vellas
BMJ: British Medical Journal 371, 1-4, 2020
Mandates: US National Institutes of Health
Review
BACE1 Inhibitors: Attractive Therapeutics for Alzheimer’s Disease
B Decourt, MM Macias, M Sabbagh, A Adem
Drug Design and Discovery in Alzheimer's Disease, 518-546, 2014
Mandates: US National Institutes of Health
Review
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population
LEM Wisse, N Spotorno, M Rossi, MJ Grothe, A Mammana, P Tideman, ...
JAMA neurology, 2024
Mandates: Knut and Alice Wallenberg Foundation, European Commission
Review
Conjugal Synucleinopathies: A Clinicopathologic Study
CH Adler, M Halverson, N Zhang, HA Shill, E Driver‐Dunckley, SH Mehta, ...
Movement Disorders, 2024
Mandates: Michael J Fox Foundation
Review
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease
A Cannizzaro, L Ronat, LM El Haffaf, A Hanganu, ADNI, M Weiner, ...
International journal of geriatric psychiatry 38 (6), e5952, 2023
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
Available somewhere: 311
Review
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ...
New England Journal of Medicine 370 (4), 322-333, 2014
Mandates: US National Institutes of Health, UK Medical Research Council
Publication and funding information is determined automatically by a computer program